1. Home
  2. IMAB vs PINE Comparison

IMAB vs PINE Comparison

Compare IMAB & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • PINE
  • Stock Information
  • Founded
  • IMAB 2014
  • PINE 2019
  • Country
  • IMAB United States
  • PINE United States
  • Employees
  • IMAB N/A
  • PINE N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • PINE Real Estate Investment Trusts
  • Sector
  • IMAB Health Care
  • PINE Real Estate
  • Exchange
  • IMAB Nasdaq
  • PINE Nasdaq
  • Market Cap
  • IMAB 200.9M
  • PINE 220.4M
  • IPO Year
  • IMAB 2020
  • PINE 2019
  • Fundamental
  • Price
  • IMAB $2.29
  • PINE $14.60
  • Analyst Decision
  • IMAB Strong Buy
  • PINE Strong Buy
  • Analyst Count
  • IMAB 2
  • PINE 8
  • Target Price
  • IMAB $6.00
  • PINE $19.00
  • AVG Volume (30 Days)
  • IMAB 1.0M
  • PINE 76.9K
  • Earning Date
  • IMAB 05-15-2025
  • PINE 07-24-2025
  • Dividend Yield
  • IMAB N/A
  • PINE 7.81%
  • EPS Growth
  • IMAB N/A
  • PINE N/A
  • EPS
  • IMAB N/A
  • PINE 0.07
  • Revenue
  • IMAB N/A
  • PINE $53,967,000.00
  • Revenue This Year
  • IMAB N/A
  • PINE $8.54
  • Revenue Next Year
  • IMAB N/A
  • PINE $3.03
  • P/E Ratio
  • IMAB N/A
  • PINE $196.22
  • Revenue Growth
  • IMAB N/A
  • PINE 14.94
  • 52 Week Low
  • IMAB $0.60
  • PINE $14.51
  • 52 Week High
  • IMAB $3.08
  • PINE $19.42
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 53.66
  • PINE 36.68
  • Support Level
  • IMAB $2.00
  • PINE $14.93
  • Resistance Level
  • IMAB $2.95
  • PINE $14.94
  • Average True Range (ATR)
  • IMAB 0.35
  • PINE 0.27
  • MACD
  • IMAB -0.07
  • PINE -0.04
  • Stochastic Oscillator
  • IMAB 30.53
  • PINE 4.82

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About PINE Alpine Income Property Trust Inc.

Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.

Share on Social Networks: